Relationships between serum markers of monocyte/macrophage activation in type 1 Gaucher's disease

被引:23
作者
Casal, JA
Lacerda, C
Pérez, LF
Pinto, RA
Miranda, MCS
Tutor, JC [1 ]
机构
[1] Hosp Clin Univ, Cent Lab, Santiago De Compostela, Spain
[2] Inst Genet Med Jacinto Magalhaes, Unidade Enzimol, Oporto, Portugal
关键词
Gaucher's disease; chitotriosidase; neopterin; angiotensin-converting enzyme; adenosine deaminase; beta-hexosaminidase; macrophage activation;
D O I
10.1515/CCLM.2002.010
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We studied 44 patients with type 1 Gaucher's disease (16 non-treated patients and 28 treated with enzyme replacement therapy). We measured serum levels of chitotriosidase (ChT), neopterin, angiotensin-converting enzyme (ACE), adenosine deaminase (ADA) and beta-hexosaminidase (Hex) and its major isoenzymes Hex A and Hex B. In the untreated group of patients, the increase in serum levels was ChT>neopterin>ACE> ADA>Hex, with all decreasing significantly in treated patients (p.<0.001). Highly significant correlations were obtained between the markers of monocyte/macrophage activation which were tested (p<0.001). However, partial correlations between serum Hex B (with Hex A constant) and ChT, ACE, neopterin and ADA did not reach statistical significance. This suggests that hepatocytes are the major cellular source of this isoenzyme. Similarly, partial correlation of ChT with neopterin, with the other variables constant, was not significant, which would suggest a different expression of these two markers in Gaucher's disease.
引用
收藏
页码:52 / 55
页数:4
相关论文
共 30 条
[1]   Plasma chitotriosidase activity in patients with β-thalassemia [J].
Barone, R ;
Di Gregorio, F ;
Romeo, MA ;
Schilirò, G ;
Pavone, L .
BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (01) :1-8
[2]   ANGIOTENSIN-CONVERTING ENZYME - CLINICAL-APPLICATIONS AND LABORATORY INVESTIGATIONS ON SERUM AND OTHER BIOLOGICAL-FLUIDS [J].
BENETEAUBURNAT, B ;
BAUDIN, B .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1991, 28 (5-6) :337-356
[3]  
Butler E, 1995, METABOLIC MOL BASES, P2641
[4]   Gaucher disease - Recommendations on diagnosis, evaluation, and monitoring [J].
Charrow, J ;
Esplin, JA ;
Gribble, TJ ;
Kaplan, P ;
Kolodny, EH ;
Pastores, GM ;
Scot, CR ;
Wappner, RS ;
Weinreb, NJ ;
Wisch, JS .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (16) :1754-1760
[5]   ALP isoenzyme separation in type 1 Gaucher disease [J].
Ciana, G ;
Tamaro, G ;
Martini, C ;
Ceschel, S ;
Cuttini, M ;
Bembi, B .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (05) :479-480
[6]   Serum chitotriosidase activity in Gaucher patients on enzyme replacement therapy (ERT) [J].
Czartoryska, B ;
Tylki-Szymanska, A ;
Górska, D .
CLINICAL BIOCHEMISTRY, 1998, 31 (05) :417-420
[7]   Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients [J].
denTandt, WR ;
vanHoof, F .
JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (03) :344-350
[8]   ANGIOTENSIN-CONVERTING ENZYME - NEW CONCEPTS CONCERNING ITS BIOLOGICAL ROLE [J].
EHLERS, MRW ;
RIORDAN, JF .
BIOCHEMISTRY, 1989, 28 (13) :5311-5318
[9]  
ELSAFI ME, 1994, EUR J CLIN CHEM CLIN, V32, P669
[10]  
ELSAFI ME, 1991, LIVER, V11, P350